The investigation aimed to identify a more practical and reliable method for PD‐L1 detection for potentially predicting the response of DLBCL to PD‐1/PD‐L1 inhibitors in clinical practice. The gene discussed is CD274; the disease is diffuse large B-cell lymphoma.